Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

National Healthcare Properties (HLTC) Change in Receivables (2016 - 2025)

Historic Change in Receivables for National Healthcare Properties (HLTC) over the last 11 years, with Q3 2025 value amounting to -$930000.0.

  • National Healthcare Properties' Change in Receivables rose 362.69% to -$930000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 million, marking a year-over-year decrease of 20819.67%. This contributed to the annual value of $794000.0 for FY2024, which is 2430.89% down from last year.
  • According to the latest figures from Q3 2025, National Healthcare Properties' Change in Receivables is -$930000.0, which was up 362.69% from -$1.2 million recorded in Q2 2025.
  • In the past 5 years, National Healthcare Properties' Change in Receivables ranged from a high of $2.8 million in Q2 2024 and a low of -$2.8 million during Q1 2024
  • Its 5-year average for Change in Receivables is -$13894.7, with a median of $217000.0 in 2023.
  • Within the past 5 years, the most significant YoY rise in National Healthcare Properties' Change in Receivables was 148468.47% (2024), while the steepest drop was 140368.66% (2024).
  • National Healthcare Properties' Change in Receivables (Quarter) stood at $92000.0 in 2021, then surged by 211.96% to $287000.0 in 2022, then plummeted by 61.32% to $111000.0 in 2023, then skyrocketed by 1484.68% to $1.8 million in 2024, then plummeted by 152.87% to -$930000.0 in 2025.
  • Its Change in Receivables stands at -$930000.0 for Q3 2025, versus -$1.2 million for Q2 2025 and -$2.2 million for Q1 2025.